F
FSD Pharma Inc
CNSX:HUGE
FSD Pharma Inc
CNSX:HUGE
Price:
7.47
CAD
14.92%
Market Closed
Market Cap:
CA$14.3m
Balance Sheet
Balance Sheet Decomposition
FSD Pharma Inc
FSD Pharma Inc
Balance Sheet Decomposition is not available for
FSD Pharma Inc
FSD Pharma Inc
Balance Sheet
FSD Pharma Inc
FSD Pharma Inc
Currency: USD
| Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
0
|
4
|
16
|
6
|
18
|
35
|
17
|
|
| Cash |
0
|
4
|
16
|
6
|
18
|
35
|
17
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
1
|
2
|
0
|
1
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
2
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
9
|
10
|
0
|
|
| Total Current Assets |
0
|
4
|
17
|
9
|
27
|
46
|
18
|
|
| PP&E Net |
0
|
6
|
9
|
9
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
9
|
9
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
17
|
13
|
16
|
12
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
7
|
|
| Long-Term Investments |
0
|
0
|
14
|
9
|
2
|
1
|
1
|
|
| Total Assets |
1
N/A
|
10
+1 838%
|
40
+286%
|
43
+9%
|
42
-2%
|
63
+50%
|
38
-39%
|
|
| Liabilities | ||||||||
| Accounts Payable |
0
|
1
|
0
|
3
|
4
|
3
|
3
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
4
|
4
|
|
| Short-Term Debt |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
1
|
2
|
1
|
1
|
0
|
|
| Total Current Liabilities |
0
|
1
|
1
|
7
|
6
|
9
|
8
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
1
+350%
|
1
+38%
|
7
+429%
|
6
-18%
|
9
+56%
|
8
-11%
|
|
| Equity | ||||||||
| Common Stock |
1
|
10
|
51
|
73
|
103
|
152
|
143
|
|
| Retained Earnings |
1
|
3
|
17
|
55
|
86
|
121
|
142
|
|
| Additional Paid In Capital |
0
|
3
|
4
|
17
|
19
|
23
|
29
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Total Equity |
0
N/A
|
9
+2 824%
|
38
+311%
|
36
-6%
|
36
+1%
|
54
+49%
|
31
-44%
|
|
| Total Liabilities & Equity |
1
N/A
|
10
+1 838%
|
40
+286%
|
43
+9%
|
42
-2%
|
63
+50%
|
38
-39%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
7
|
7
|
7
|
8
|
19
|
40
|
39
|
|
Switch to:
Switch to:
See Also
Discover More
